ClinicalTrials.Veeva

Menu

Inflammatory Responses in Solitary and Multiple Erythema Migrans

U

University Medical Centre Ljubljana

Status

Completed

Conditions

Erythema Migrans

Treatments

Other: antibiotic treatment

Study type

Observational

Funder types

Other

Identifiers

NCT03980015
MEM vs EM cyto

Details and patient eligibility

About

The investigators will evaluate differences in host immune responses (levels of cytokines and chemokines, representative of innate, Th1, and Th17 immune responses) in acute sera from adult patients with solitary or multiple erythema migrans.

Enrollment

134 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • erythema migrans in patients > 18 years
  • Borrelia afzelii isolated from skin

Exclusion criteria

  • pregnancy or immunocompromising conditions
  • taking antibiotic with antiborrelial activity within 10 days

Trial design

134 participants in 1 patient group

erythema migrans
Description:
patients with erythema migrans
Treatment:
Other: antibiotic treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems